GMG
Clinical trials for GMG explained in plain language.
Never miss a new study
Get alerted when new GMG trials appear
Sign up with your email to follow new studies for GMG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new tapering schedule help MG patients reduce steroids safely?
Disease control Recruiting nowThis study looks at whether a planned reduction of oral steroids is safe and effective for adults with generalized myasthenia gravis who are already receiving the drug ravulizumab. About 75 participants will follow a step-by-step tapering schedule. The goal is to see if they can …
Matched conditions: GMG
Phase: PHASE4 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 06:09 UTC
-
New hope for kids with rare Muscle-Weakening disease
Disease control Recruiting nowThis study tests a drug called gefurulimab in 12 children (ages 6 to 17) who have generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see how the drug moves through the body, how safe it is, and if it helps improve symptoms. Participants will re…
Matched conditions: GMG
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 06:08 UTC
-
New hope for MG patients: study tests safer drug combos
Disease control Recruiting nowThis study is testing how safe and effective different drug combinations are for people with myasthenia gravis, a condition that causes muscle weakness. Researchers want to find treatments that reduce side effects and improve quality of life. About 70 adults with generalized MG a…
Matched conditions: GMG
Sponsor: argenx • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New drug combo aims to ease severe muscle weakness in MG patients
Disease control Recruiting nowThis study tests whether adding empasiprubart to the standard treatment efgartigimod can further improve symptoms in people with generalized myasthenia gravis (gMG) who still have muscle weakness. About 70 adults with a specific antibody type (AChR-Ab positive) will receive the c…
Matched conditions: GMG
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
New study tracks Real-World impact of gMG treatment in italy
Knowledge-focused Recruiting nowThis study follows 100 adults in Italy with generalized myasthenia gravis (gMG) who are already starting treatment with efgartigimod as part of their routine care. Researchers will track changes in symptoms and daily functioning over up to 23 months using patient surveys and doct…
Matched conditions: GMG
Sponsor: argenx • Aim: Knowledge-focused
Last updated May 26, 2026 05:50 UTC